| GWAS |
- Advanced age-related macular degeneration ( 26691988
)
- Age-related macular degeneration ( 20385819
32741009
23577725
23536807
23455636
23326517
22694956
21665990
20861866
15761122
20385826
)
- Age-related macular degeneration (choroidal neovascularisation) ( 22705344
)
- Age-related macular degeneration (extreme sampling) ( 23577725
)
- Age-related macular degeneration (geographic atrophy) ( 22705344
)
- Age-related macular degeneration (MTAG) ( 32277175
)
- Aspartate aminotransferase levels ( 33547301
)
- Chronic central serous retinopathy ( 30073298
30480742
)
- Circulating myeloperoxidase levels (serum) ( 23620142
)
- Complement C3 and C4 levels ( 23028341
)
- Complement C3 levels ( 33941608
)
- Complement factor H binding to malondialdehyde ( 32321835
)
- Complement factor H levels ( 34260947
)
- Complement factor H-related protein 2 levels ( 34260947
)
- Complement factor H-related protein 3 levels ( 34260947
)
- Complement factor H-related protein 4A levels ( 34260947
)
- Complement factor H-related protein 5 levels ( 34260947
)
- Disease progression in age-related macular degeneration ( 29346644
)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644
)
- Disease progression to geographic atrophy form in age-related macular degeneration ( 29346644
)
- Early age-related macular degeneration ( 32843070
)
- Exudative age-related macular degeneration ( 25629512
)
- Fuchs's corneal dystrophy ( 28358029
)
- Liver enzyme levels (alanine transaminase) ( 33972514
)
- Matrix metalloproteinase-8 levels ( 29212897
)
- Meningococcal disease ( 20694013
)
- Neovascular age-related macular degeneration ( 28703135
)
- Nephropathy ( 21399633
)
- Post bronchodilator FEV1/FVC ratio in COPD ( 26634245
)
- Rheumatic heart disease ( 34106200
)
- Serum C3d:C3 ratio (systemic complement activation) ( 29398083
)
- Sub-foveal choroidal thickness ( 29844195
)
- Systemic lupus erythematosus ( 28714469
)
- Waist-to-hip ratio adjusted for BMI ( 34021172
)
|
|